Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Bayer Announces Christoph Koenen as New Global Head of Clinical Development and Operations within Pharmaceuticals Research and Development at Bayer
Bayer today announced Christoph Koenen as the new Global Head of Clinical Development and Operations […]
Gilead and Kite Oncology Demonstrate Broad Leadership in Cell Therapy and Expanding Blood Cancer Pipeline
Gilead Sciences, Inc. (Nasdaq: GILD) and Kite, a Gilead Company, today announced that data at […]
Provention Bio Announces Appointment of Thierry Chauche as Chief Financial Officer
Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today […]
WELL Health Adds Chief Medical Officer Sean Kelly to Leadership Team
Well Health Inc., a SaaS digital health leader in patient communications and 2021 Best in KLAS […]
Biomunex Pharmaceuticals’ Breakthrough Immunotherapy Project Receives Grants Close to €3 Million
Biomunex Pharmaceuticals, a biopharmaceutical company that develops cutting-edge immunotherapy through the discovery and development of bi- and multi-specific […]
Closed Loop Medicine Closes £13 Million Financing
Closed Loop Medicine (the “Company”), the global leader in the development of single prescription drug […]
SAGA Diagnostics Enters into Development Agreement with AstraZeneca
SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology […]
BioNet and Sartorius’ Company BIA Separations Collaborate on Production Process Development of mRNA Vaccines
BioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of […]
Draper Esprit Leads $17.5 Million Series A in Hypertension Health-tech Firm Aktiia
Draper Esprit, a leading venture capital firm investing in and developing high growth technology businesses, […]
Mogrify Appoints Tom Graney as Non-Executive Director, Audit Chair and Capital Markets Advisor
Mogrify Limited (Mogrify®), a biopharmaceutical company pioneering the development of a new class of in […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more